Cullgen (shanghai),inc
Clinical trials sponsored by Cullgen (shanghai),inc, explained in plain language.
-
New pill targets Hard-to-Treat cancers with specific genetic flaw
Disease control Recruiting nowThis early-stage trial is testing a new oral drug called CG001419 for adults with advanced solid tumors that have specific changes in the NTRK gene and have stopped responding to standard treatments. The study first aims to find a safe and effective dose, then see if the drug can…
Phase: PHASE1, PHASE2 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for patients Who've run out of options: early trial tests novel blood cancer drug
Disease control Recruiting nowThis is a first-in-human study to test a new drug called CG009301 in adults with blood cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. About 45 participants will receive the t…
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC